{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:03:54Z","timestamp":1793196234063,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006544.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000}}],"reference-count":112,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006544.pub3","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T08:57:01Z","timestamp":1515574621000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prostanoids for critical limb ischaemia"],"prefix":"10.1002","volume":"2018","author":[{"given":"Valeria","family":"Vietto","sequence":"first","affiliation":[{"name":"Hospital Italiano de Buenos Aires; Family and Community Medicine Service; Buenos Aires Argentina"},{"name":"Instituto Universitario Hospital Italiano; Argentine Cochrane Centre; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan VA","family":"Franco","sequence":"additional","affiliation":[{"name":"Instituto Universitario Hospital Italiano; Argentine Cochrane Centre; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Saenz","sequence":"additional","affiliation":[{"name":"Unidad Asistencial Dr. C\u00e9sar Milstein; Internal Medicine; La Rioja 951 Ciudad Aut\u00f3noma de Buenos Aires Buenos Aires Argentina C1221ACI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Cytryn","sequence":"additional","affiliation":[{"name":"Hospital Italiano de Buenos Aires; Family and Community Medicine Service; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Chas","sequence":"additional","affiliation":[{"name":"Hospital Italiano de Buenos Aires; Cardiovascular Surgery Department; Buenos Aires Argentina Per\u00f3n 4190"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ciapponi","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Dr. Emilio Ravignani 2024 Buenos Aires Capital Federal Argentina C1414CPV"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0952-3278(93)90163-Q","article-title":"Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study","volume":"49","author":"Altstaedt","year":"1993","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0002|cit2","first-page":"229","article-title":"Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost","volume":"10","author":"Balzer","year":"1991","journal-title":"International Angiology"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0003|cit3","first-page":"249","article-title":"Analysis of side effects of prostanoid-based treatment in patients suffering from critical ischaemia of the lower limbs","volume":"5","author":"Bandiera","year":"1995","journal-title":"Chronica Dermatologica"},{"issue":"8320","key":"10.1002\/14651858.CD006544.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(83)91625-2","article-title":"Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial","volume":"1","author":"Belch","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0005|cit5","first-page":"150","article-title":"The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia","volume":"30","author":"Belch","year":"2011","journal-title":"International Angiology"},{"issue":"51-52","key":"10.1002\/14651858.CD006544.pub3-BIB0006|cit6","first-page":"1501","article-title":"Peripheral arterial occlusive disease stage III and IV","volume":"40","author":"B\u00f6hme","year":"1989","journal-title":"Medizinische Welt"},{"issue":"5","key":"10.1002\/14651858.CD006544.pub3-BIB0007|cit7","first-page":"209","article-title":"Naftidrofuryl in comparison to alprostadil in peripheral arterial occlusive disease stage III and IV","volume":"45","author":"B\u00f6hme","year":"1994","journal-title":"Medizinische Welt"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jvs.2005.11.041","article-title":"Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia","volume":"43","author":"Brass","year":"2006","journal-title":"Journal of Vascular Surgery"},{"issue":"40","key":"10.1002\/14651858.CD006544.pub3-BIB0009|cit9","first-page":"1477","article-title":"Iloprost in the treatment of ischemic tissue lesions in diabetics: results of a placebo-controlled multicenter study with a stable prostacyclin derivative","volume":"120","author":"Brock","year":"1990","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0010|cit10","unstructured":"Castagno PL Molfetta L Merlo M Barile G Violato F Buzzacchino A Prospects of prostanoid therapy. Preliminary results Minerva Cardioangiologica 2000 9 18"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0011|cit11","first-page":"369","article-title":"Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructable peripheral arterial occlusive disease","volume":"100","author":"Cronenwett","year":"1986","journal-title":"Surgery"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0012|cit12","first-page":"133","article-title":"Intravenous prostaglandin E1 therapy in patients with stage III peripheral arterial disease - a double-blind placebo controlled study","volume-title":"Prostaglandin E1 Wirkungen und Therapeutische Wirksamkeit","author":"Diehm","year":"1988"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0013|cit13","first-page":"204","article-title":"Treatment of rest pain in peripheral arterial occlusive disease (PVVK) with intravenous prostaglandin infusion","volume":"20","author":"Diehm","year":"1987","journal-title":"Vasa Supplementum"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0014|cit14","first-page":"52","article-title":"Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD) - a preliminary report on a placebo-controlled double-blind study","volume":"17","author":"Diehm","year":"1987","journal-title":"Vasa Supplementum"},{"issue":"20","key":"10.1002\/14651858.CD006544.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-2008-1066673","article-title":"Iloprost, a stable prostacyclin derivative, in stage IV arterial disease. A placebo-controlled multicentre study","volume":"114","author":"Diehm","year":"1989","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"5","key":"10.1002\/14651858.CD006544.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0950-821X(05)80337-8","article-title":"Treatment of limb threatening ischaemia with intravenous iloprost: a randomised double-blind placebo controlled study","volume":"5","author":"Dormandy","year":"1991","journal-title":"European Journal of Vascular Surgery"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0017|cit17","first-page":"558","article-title":"Controlled randomized study of an oral prostacyclin analogue (iloprost) in patients with inoperable stage III and IV leg ischaemia","volume":"83","author":"Dormandy","year":"1996","journal-title":"British Journal of Surgery"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/ejvs.2000.1175","article-title":"Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. Study A","volume":"20","author":"Dormandy","year":"2000","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/ejvs.2000.1175","article-title":"Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. Study B","volume":"20","author":"Dormandy","year":"2000","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0020|cit20","unstructured":"Esato K Yasuda K Abe T Hoshino S Ishimaru S Hori G Studies on the clinical efficacy and safety of TTC-909 in the treatment of peripheral arterial occlusive disease: a multi-center double-blind comparison with Alprostadil incorporated in lipid microspheres Rinsho Iyaku 1995 2111 41"},{"issue":"5","key":"10.1002\/14651858.CD006544.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF03259752","article-title":"Treatment of lower limb ischaemia due to atherosclerosis in diabetic and nondiabetic patients with iloprost, a stable analogue of prostacyclin.\u00a0Results of a French Multicentre Trial","volume":"3","author":"Guilmot","year":"1991","journal-title":"Drug Investigation"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0022|cit22","first-page":"540","article-title":"Long-term infusion of epoprostenol (prostacyclin) in patients with occlusive arteriopathy stage III-IV","volume":"89","author":"Hossmann","year":"1983","journal-title":"Verhandlungen der Deutschen Gesellschaft fur Innere Medizin"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Jogestrand T Olsson AG The effect of intravenous prostaglandin E1 on ischaemic pain and on leg blood-flow in subjects with peripheral artery disease: a double-blind controlled study Clinical Physiology (Oxford, England) 1985 495 502","DOI":"10.1111\/j.1475-097X.1985.tb00762.x"},{"issue":"12","key":"10.1002\/14651858.CD006544.pub3-BIB0024|cit24","first-page":"644","article-title":"A randomized study on patients with peripheral arterial occlusive disease (PAOD) stage III and IV","volume":"18","author":"Karnik","year":"1986","journal-title":"Herz Kreislauf"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/j.1552-4604.1991.tb01891.x","article-title":"The effect of ciprostene in patients with peripheral vascular disease (PVD) characterized by ischemic ulcers","volume":"31","author":"Linet","year":"1991","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0026|cit26","unstructured":"Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV (ESPECIAL) clinicaltrials.gov\/ct2\/show\/NCT00596752."},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0027|cit27","first-page":"196","article-title":"Intra-arterial prostacyclin compared to praxilene in the management of severe lower limb ischaemia: a double blind trial","volume":"28","author":"Negus","year":"1987","journal-title":"Journal of Cardiovascular Surgery (Torino)"},{"issue":"5","key":"10.1002\/14651858.CD006544.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0950-821X(05)80784-4","article-title":"A stable prostacyclin analogue (Iloprost) in the treatment of ischaemic ulcers of the lower limb","volume":"4","author":"Norgren","year":"1990","journal-title":"European Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Reisin L Marmor A Rabinowitz B Bernink PJ Caspi A Ruzyllo W Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure American Journal of Therapeutics 1997 365 74","DOI":"10.1097\/00045391-199711000-00005"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0030|cit30","first-page":"39","article-title":"Prostaglandin E1 intra-arterial infusion therapy in patients with ischemic ulcer of the extremities","volume":"3","author":"Sakaguchi","year":"1084","journal-title":"International Angiology"},{"issue":"6","key":"10.1002\/14651858.CD006544.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.plefa.2003.10.006","article-title":"Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia","volume":"70","author":"Schellong","year":"2004","journal-title":"Prostaglandins Leukotrienes and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0032|cit32","unstructured":"Rhodes RS Heard SE Detrimental effect of high-dose prostaglandin Esub 1 in the treatment of ischemic ulcers Surgery 1983 839 42"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0033|cit33","first-page":"160","article-title":"Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial","volume":"1","author":"Schuler","year":"1984","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0034|cit34","first-page":"164","article-title":"Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease","volume":"35 (Suppl)","author":"Stiegler","year":"1992","journal-title":"VASA"},{"issue":"7","key":"10.1002\/14651858.CD006544.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/bjs.1800710710","article-title":"Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial","volume":"71","author":"Telles","year":"1984","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0036|cit36","first-page":"39","article-title":"Prostaglandin E1 in chronic arterial disease - a multicenter study","volume":"17","author":"Trubestein","year":"1987","journal-title":"VASA Supplementum"},{"issue":"24","key":"10.1002\/14651858.CD006544.pub3-BIB0037|cit37","first-page":"955","article-title":"Prostaglandin E1 in stage III and IV arterial occlusive disease: results of a multi-center trial","volume":"112","author":"Trubestein","year":"1987","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0038|cit38","first-page":"44","article-title":"Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease - a controlled randomised multicenter study","volume":"28","author":"Trubestein","year":"1989","journal-title":"VASA Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0039|cit39","first-page":"53","article-title":"Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III","volume":"2","author":"Arosio","year":"1998","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0040|cit40","first-page":"15","article-title":"Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease Fontaine stage IV. DAWID Study Group","volume":"27","author":"Beischer","year":"1998","journal-title":"VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006544.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-130-5-199903020-00005","article-title":"Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1","volume":"130","author":"Bertele","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0042|cit42","first-page":"62","article-title":"Prostacyclin (iloprost) as an adjuvant in local surgical therapy of stage IV arterial occlusive disease - is quantification of the therapeutic effect possible with tcPO2 measurements?","volume":"24","author":"Breuer","year":"1995","journal-title":"VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF01616273","article-title":"Effects of iloprost, either administered for 1 week or 4 weeks, on systemic hemodynamics, peripheral blood flow, and exercise tolerance in patients with peripheral occlusive arterial disease at Leriche-Fontaine stage III","volume":"7","author":"Ceriello","year":"1998","journal-title":"International Journal of Angiology"},{"issue":"10","key":"10.1002\/14651858.CD006544.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/039139880502801012","article-title":"Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease","volume":"28","author":"Paolo","year":"2005","journal-title":"International Journal of Artificial Organs"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0045|cit45","unstructured":"Esato K Yasuda K Abe T Hoshino S Ishimaru S Hori G Clinical study of TTC-909 (Prostacyclin derivative, clinprost incorporated in lipid microspheres) in patients with peripheral arterial occlusive disease: establishment of optimal dose in multi-center double-blind comparative study Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1995 2083 110"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0046|cit46","unstructured":"Esato K Yasuda K Abe T Hoshino S Ishimaru S Hori G Clinical study of TTC-909 (Prostacyclin derivative, clinprost incorporated in lipid microspheres) in patients with peripheral arterial occlusive disease: establishment of optimal dose in multi-center double-blind comparative study Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1997 5595 622"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0047|cit47","unstructured":"Feng K Tan JF Chen Y Treatment of lower extremity diabetic atherosclerotic obliterans with shuxuetong injection Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese Journal of Integrated Traditional and Western Medicine \/ Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 2009 255 7"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0048|cit48","first-page":"522A","article-title":"Treatment of ischaemic ulceration or rest pain with intravenous Iloprost: a double-blind placebo controlled study","volume":"Suppl 1","author":"Fonseca","year":"1991","journal-title":"Diabetes 40"},{"issue":"7","key":"10.1002\/14651858.CD006544.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0011-393X(03)00125-5","article-title":"Comparison of beraprost and ticlopidine in Chinese patients with chronic peripheral arterial occlusion: a multicenter, single blind, randomized, controlled study","volume":"64","author":"Guan","year":"2003","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0050|cit50","first-page":"13","article-title":"Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion","volume":"20","author":"Heidrich","year":"1991","journal-title":"VASA"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006544.pub3-BIB0051|cit51","first-page":"104","article-title":"Alprostadil in the treatment of patients with severe peripheral arterial occlusive disease (PAOD) not amenable to surgery: results of a randomized, placebo-controlled multicenter study","volume":"14","author":"Menzoian","year":"1995","journal-title":"International Angiology"},{"issue":"6","key":"10.1002\/14651858.CD006544.pub3-BIB0052|cit52","first-page":"1243","article-title":"Medical therapy in diabetic angiopathy with inoperable critical limb ischemia (CLI) - a randomized, between-patients study to compare the effects of iloprost (I) vs pentoxyfilline (P)","volume":"69","author":"Mingardi","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0053|cit53","unstructured":"Efficacy\/safety of ecraprost in lipid emulsion for treatment of critical leg ischemia due to peripheral arterial disease clinicaltrials.gov\/ct2\/show\/NCT00059644."},{"key":"10.1002\/14651858.CD006544.pub3-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Nizankowski R Kr\u00f3likowski W Bielatowicz J Szczeklik A Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study Thrombosis Research 1985 21 8","DOI":"10.1016\/0049-3848(85)90029-5"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0055|cit55","first-page":"iii487","article-title":"Effect of beraprost sodium (PGI2 analogue) on peripheral arterial disease (PAD) in patients on hemodialysis: result from a multicenter randomized prospective interventional study","volume":"3","author":"Ohtake","year":"2010","journal-title":"Nephrology Dialysis Transplantation Plus"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Ohtake T Sato M Nakazawa R Kondoh M Miyaji T Moriya H Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patients Therapeutic Apheresis and Dialysis 2014 1 8 10.1111\/1744-9987.12051","DOI":"10.1111\/1744-9987.12051"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0939-4753(04)80003-6","article-title":"Prostaglandin E1 versus lumbar sympathectomy in the treatment of\u00a0peripheral arterial occlusive disease: randomised study of 86 patients","volume":"14","author":"Petronella","year":"2004","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0058|cit58","unstructured":"Sakaguchi-Shukichi Evaluation of the efficacy of beraprost sodium (PGI2 analogue) in chronic arterial occlusion: a double-blind comparative study with ticlopidine hydrochloride Rinsho to Kenkyu 1990 575 84"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006544.pub3-BIB0059|cit59","first-page":"201","article-title":"Iloprost vs nitrates and aspirin in the treatment of geriatric patients suffering of peripheral arterial obliterative disease","volume":"14","author":"Schwarz","year":"1995","journal-title":"International Angiology"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"Sert M Soydas B Aikimbaev K Tetiker T Effects of iloprost (a prostacyclin analogue) on the endothelial dysfunction and foot ulcers in diabetic patients with peripheral arterial disease International Journal of Diabetes and Metabolism 2008 7 11","DOI":"10.1159\/000497646"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0061|cit61","unstructured":"Weiss T Griesshaber J Rogatti W Kistner O Hsu E Jansen T Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities VASA Supplementum 1991 341 2"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0062|cit62","unstructured":"Ylitalo P Kaukinen S Reinikainen P Salenius JP Vapaatalo H A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease International Journal of Clinical Pharmacology, Therapy, and Toxicology 1990 197 204"},{"issue":"6","key":"10.1002\/14651858.CD006544.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0741-5214(92)90417-7","article-title":"Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease","volume":"16","author":"Albers","year":"1992","journal-title":"Journal of Vascular Surgery"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD006544.pub3-BIB0065|cit65","first-page":"1","article-title":"Second European Consensus Document on chronic critical leg ischemia","volume":"84","author":"Anonymous","year":"1991","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD006544.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1067\/mva.2001.119749","article-title":"Natural history of claudication: long-term serial follow-up study of 1244 claudicants","volume":"34","author":"Aquino","year":"2001","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1078-5884(11)60009-9","article-title":"Chapter I: Definitions, epidemiology, clinical presentation and prognosis","volume":"42 (Suppl 2)","author":"Becker","year":"2011","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"51","key":"10.1002\/14651858.CD006544.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1556\/OH.2011.29277","article-title":"Effectiveness of prostanoids in patients with critical leg ischemia","volume":"152","author":"Brodszky","year":"2011","journal-title":"Orvosi Hetilap"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011033.pub3","article-title":"Pharmacological treatment for Buerger's disease","author":"Cacione","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006544.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1024\/0301-1526.33.3.137","article-title":"Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV","volume":"33","author":"Creutzig","year":"2004","journal-title":"Vasa"},{"issue":"9","key":"10.1002\/14651858.CD006544.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0072|cit72","first-page":"52","article-title":"Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD) - a preliminary report on a placebo-controlled double-blind study","volume":"17","author":"Diehm","year":"1987","journal-title":"Vasa Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1358863X9600100212","article-title":"Prostanoid drug therapy for peripheral arterial occlusive disease - the European experience","volume":"1","author":"Dormandy","year":"1996","journal-title":"Vascular Medicine"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD006544.pub3-BIB0074|cit74","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"Journal of Vascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Dua","year":"2016","journal-title":"Techniques in Vascular and Interventional Radiology"},{"issue":"11","key":"10.1002\/14651858.CD006544.pub3-BIB0076|cit76","first-page":"1465","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2016","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0077|cit77","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Computer program]. Version accessed May 2017 Hamilton (ON): McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from www.gradepro.org"},{"issue":"7651","key":"10.1002\/14651858.CD006544.pub3-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"GRADE: what is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD006544.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1024\/0301-1526\/a000298","article-title":"Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials","volume":"42","author":"Hammer","year":"2013","journal-title":"VASA Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0081|cit81","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0082|cit82","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"11","key":"10.1002\/14651858.CD006544.pub3-BIB0083|cit83","first-page":"463","article-title":"ACC\/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"issue":"19","key":"10.1002\/14651858.CD006544.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.115.016424","article-title":"Population-based study of incidence, risk factors, outcome, and prognosis of ischemic peripheral arterial events: implications for prevention","volume":"132","author":"Howard","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD006544.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.avsg.2014.04.005","article-title":"Octogenarians develop infrapopliteal arterial occlusive disease in the absence of traditional risk factors","volume":"28","author":"Hylton","year":"2014","journal-title":"Annals of Vascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD006544.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-130-5-199903020-00005","article-title":"Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1","volume":"130","author":"The ICAI Group","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"6555","key":"10.1002\/14651858.CD006544.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.293.6555.1137","article-title":"Fate in intermittent claudication: outcome and risk factors","volume":"293","author":"Jelnes","year":"1986","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"issue":"8","key":"10.1002\/14651858.CD006544.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome","volume":"24","author":"Jude","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0089|cit89","first-page":"133","article-title":"A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease","volume":"13","author":"Loosemore","year":"1994","journal-title":"International Angiology"},{"issue":"9","key":"10.1002\/14651858.CD006544.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0003319715626849","article-title":"Low rates of revascularization and high in-hospital mortality in patients with ischemic lower limb amputation: morbidity and mortality of ischemic amputation","volume":"67","author":"Malyar","year":"2016","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD006544.pub3-BIB0091|cit91","first-page":"502","article-title":"Long-term clinical outcomes in critical limb ischemia - a retrospective study of 181 patients","volume":"20","author":"Melillo","year":"2016","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5-6","key":"10.1002\/14651858.CD006544.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1538574414539397","article-title":"Clinical effectiveness of gene therapy on critical limb ischemia: a meta-analysis of 5 randomized controlled clinical trials","volume":"48","author":"Miao","year":"2014","journal-title":"Vascular and Endovascular Surgery"},{"issue":"12","key":"10.1002\/14651858.CD006544.pub3-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008347.pub3","article-title":"Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia","author":"Moazzami","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD006544.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/bjs.7092","article-title":"Epidemiological study of lower limb amputation in England between 2003 and 2008","volume":"97","author":"Moxey","year":"2010","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33 (Suppl 1)","author":"Norgren","year":"2007","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1532-5415.2007.01123.x","article-title":"Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004","volume":"55","author":"Ostchega","year":"2007","journal-title":"Journal of the American Geriatrics Society"},{"issue":"9","key":"10.1002\/14651858.CD006544.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)","volume":"65","author":"Patel","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0098|cit98","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000986.pub3","article-title":"Prostanoids for intermittent claudication","author":"Robertson","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0100|cit100","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"10","key":"10.1002\/14651858.CD006544.pub3-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009366","article-title":"Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease","author":"Sen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006544.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"843-9, 849.e1","DOI":"10.1016\/j.jvs.2010.04.057","article-title":"Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment","volume":"52","author":"Sprengers","year":"2010","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.avsg.2011.07.014","article-title":"Predicting functional status following amputation after lower extremity bypass","volume":"26","author":"Suckow","year":"2012","journal-title":"Annals of Vascular Surgery"},{"issue":"4","key":"10.1002\/14651858.CD006544.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.avsg.2014.12.005","article-title":"Domains that determine quality of life in vascular amputees","volume":"29","author":"Suckow","year":"2015","journal-title":"Annals of Vascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"e002938","DOI":"10.1161\/JAHA.115.002938","article-title":"Critical limb ischemia: current trends and future directions","volume":"5","author":"Teraa","year":"2016","journal-title":"Journal of the American Heart Association"},{"key":"10.1002\/14651858.CD006544.pub3-BIB0107|cit107","first-page":"44","article-title":"Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease - a controlled randomised multicenter study","volume":"28","author":"Trubestein","year":"1989","journal-title":"Vasa Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004001.pub3","article-title":"Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia","author":"Ubbink","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1358863X9400500201","article-title":"prostaglandins in critical limb ischemia","volume":"5","author":"Verstraete","year":"1994","journal-title":"Vascular Medicine Review"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jdiacomp.2015.09.006","article-title":"Prostanoids in patients with peripheral arterial disease: a meta-analysis of placebo-controlled randomized clinical trials","volume":"30","author":"Vitale","year":"2016","journal-title":"Journal of Diabetes and Its Complications"},{"issue":"2","key":"10.1002\/14651858.CD006544.pub3-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006544","article-title":"Prostanoids for critical limb ischemia","author":"Ruffolo","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006544.pub3-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006544.pub2","article-title":"Prostanoids for critical limb ischaemia","author":"Ruffolo","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006544.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T14:20:42Z","timestamp":1751206842000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006544.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006544.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]}}}